Immunotherapy Strategies for the Prevention and Treatment of Distinct Stages of Type 1 Diabetes: An Overview
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunotherapy Strategies for the Prevention and Treatment of Distinct Stages of Type 1 Diabetes: An Overview
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 6, Pages 2103
Publisher
MDPI AG
Online
2020-03-19
DOI
10.3390/ijms21062103
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification and functional characterization of CD8+ T regulatory cells in type 1 diabetes patients
- (2019) Marsha Pellegrino et al. PLoS One
- BMI, Mortality, and Cardiovascular Outcomes in Type 1 Diabetes: Findings Against an Obesity Paradox
- (2019) Jon Edqvist et al. DIABETES CARE
- An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
- (2019) Kevan C. Herold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Omega-3 Fatty Acids on Immune Cells
- (2019) Saray Gutiérrez et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Genetics of type 1 diabetes
- (2018) Catherine C .Robertson et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Immunological biomarkers for the development and progression of type 1 diabetes
- (2018) Chantal Mathieu et al. DIABETOLOGIA
- The Environmental Determinants of Diabetes in the Young (TEDDY) Study: 2018 Update
- (2018) Marian Rewers et al. Current Diabetes Reports
- Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes
- (2017) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and efficacy of autoantigen-specific therapy with 2 doses of alum-formulated glutamate decarboxylase in children with multiple islet autoantibodies and risk for type 1 diabetes: A randomized clinical trial
- (2017) Helena Elding Larsson et al. PEDIATRIC DIABETES
- Antithymocyte Globulin Plus G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders With Established Type 1 Diabetes
- (2016) Michael J. Haller et al. DIABETES
- JDRF's vision and strategy for prevention of type 1 diabetes
- (2016) Richard Insel et al. PEDIATRIC DIABETES
- The DIPP project: 20 years of discovery in type 1 diabetes
- (2016) Michael J Haller et al. PEDIATRIC DIABETES
- Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
- (2015) Richard A. Insel et al. DIABETES CARE
- OGTT and random plasma glucose in the prediction of type 1 diabetes and time to diagnosis
- (2015) Olli Helminen et al. DIABETOLOGIA
- Expression of PD-1 Molecule on Regulatory T Lymphocytes in Patients with Insulin-Dependent Diabetes Mellitus
- (2015) Valentina Perri et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Type 1 diabetes immunotherapy using polyclonal regulatory T cells
- (2015) Jeffrey A. Bluestone et al. Science Translational Medicine
- Therapy of type 1 diabetes with CD4+CD25highCD127-regulatory T cells prolongs survival of pancreatic islets — Results of one year follow-up
- (2014) Natalia Marek-Trzonkowska et al. CLINICAL IMMUNOLOGY
- Low-Dose Otelixizumab Anti-CD3 Monoclonal Antibody DEFEND-1 Study: Results of the Randomized Phase III Study in Recent-Onset Human Type 1 Diabetes
- (2014) Ronnie Aronson et al. DIABETES CARE
- Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetes
- (2014) Michael J. Haller et al. JOURNAL OF CLINICAL INVESTIGATION
- Acceleration of the Loss of the First-Phase Insulin Response During the Progression to Type 1 Diabetes in Diabetes Prevention Trial-Type 1 Participants
- (2013) J. M. Sosenko et al. DIABETES
- Teplizumab Preserves C-Peptide in Recent-Onset Type 1 Diabetes: Two-Year Results From the Randomized, Placebo-Controlled Protege Trial
- (2013) W. Hagopian et al. DIABETES
- B-Lymphocyte Depletion With Rituximab and -Cell Function: Two-Year Results
- (2013) M. D. Pescovitz et al. DIABETES CARE
- Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children
- (2013) Anette G. Ziegler et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
- (2013) Antoinette Moran et al. LANCET
- The putative role of the C1858T polymorphism of protein tyrosine phosphatase PTPN22 gene in autoimmunity
- (2012) Elena Gianchecchi et al. AUTOIMMUNITY REVIEWS
- Unknown
- (2012) Shohreh Issazadeh-Navikas et al. MOLECULAR MEDICINE
- GAD65 Antigen Therapy in Recently Diagnosed Type 1 Diabetes Mellitus
- (2012) Johnny Ludvigsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial
- (2011) Nicole Sherry et al. LANCET
- Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
- (2011) Tihamer Orban et al. LANCET
- Genetics, pathogenesis and clinical interventions in type 1 diabetes
- (2010) Jeffrey A. Bluestone et al. NATURE
- The Environmental Determinants of Diabetes in the Young (TEDDY) Study
- (2009) Annals of the New York Academy of Sciences
- Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients
- (2009) B. Keymeulen et al. BLOOD
- Etanercept Treatment in Children With New-Onset Type 1 Diabetes: Pilot randomized, placebo-controlled, double-blind study
- (2009) L. Mastrandrea et al. DIABETES CARE
- Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
- (2009) Mark D. Pescovitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial
- (2008) Kirsti Näntö-Salonen et al. LANCET
- GAD Treatment and Insulin Secretion in Recent-Onset Type 1 Diabetes
- (2008) Johnny Ludvigsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results
- (2008) Jeffrey L Mahon et al. PEDIATRIC DIABETES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now